Allarity Therapeutics, Inc.

ALLR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$24,515-$11,901-$16,058-$26,648
Dep. & Amort.$9$37$60$106
Deferred Tax-$446$97-$1,612$20
Stock-Based Comp.$71-$71$1,752$6,368
Change in WC$63$3,352-$328$5,570
Other Non-Cash$7,466-$4,259-$631-$466
Operating Cash Flow-$17,352-$12,745-$16,817-$15,050
Investing Activities
PP&E Inv.-$298$0-$18$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$809$1,000
Investing Cash Flow-$298$0$791$1,000
Financing Activities
Debt Repay.$0-$2,649$1,000$969
Stock Issued$40,292$16,895$0$32,125
Stock Repurch.-$3,500$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$3,251-$2,311$725
Financing Cash Flow$36,792$10,995-$1,311$33,819
Forex Effect$225-$113-$189-$512
Net Chg. in Cash$19,367-$1,863-$17,526$19,257
Supplemental Information
Beg. Cash$166$2,029$19,555$298
End Cash$19,533$166$2,029$19,555
Free Cash Flow-$17,650-$12,745-$16,835-$15,050